ArticleNeuro-oncology practice2022

Short-term outcomes associated with temozolomide or PCV chemotherapy for 1p/19q-codeleted WHO grade 3 oligodendrogliomas: A national evaluation.

Nayan Lamba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.